tirzepatide and bupropion Contrave for Weight Loss | Doctor-Prescribed Weight Loss Pills GLP-1 (Semaglutide & Tirzepatide) Weight

Occurred in 8.8% of participants on 9 mg and 20.9% on 12 mg, compared to 0.7% on placebo Dose-dependent (higher dose, higher risk) Generally described as mild Rarely led to discontinuation Why this matters: Dysesthesia was not reported in the Phase 2 trial

Eli Lilly has signalled intent to file with the FDA in the United States and the EMA in Europe after the TRIUMPH-1, 2, and 3 readouts

This pricing model means patients access the same therapeutic molecule at a fraction of the cost

Ozempic, on the other hand, helps people with type 2 diabetes manage blood sugar and weight but isnt suitable for type 1 diabetes or rapid blood sugar control